Table 2.
Compound | Test conc. PL (μM) | hERGIC50 PL (μM) | hERG IC50 PC (μM) |
---|---|---|---|
Mean ± SE | |||
Amiodarone | 0.01–0.03–0.1–0.3 | 0.17 ± 0.03 | 0.070 (Ridley et al., 2004) |
Astemizole | 0.001–0.003–0.01–0.03 | 0.012 ± 0.0008 | 0.006 |
Bepridil | 0.01–0.03–0.1–0.3 | 0.065 ± 0.012 | 0.27 |
Captopril | 1–10–100–1000 | >1000 | >1000 |
Cisapride | 0.001–0.01–0.1–1 | 0.022 ± 0.005 | 0.024 (Walker et al., 1999) |
Clemastine | 0.001–0.01–0.1–1 | 0.006 ± 0.002 | 0.012 (Ridley et al., 2006) |
Dofetilide | 0.001–0.01–0.1–1 | 0.058 ± 0.018 | 0.01 (Du et al., 2011) |
E-4031 | 0.0003–0.003–0.03–0.3 | 0.001 ± 0.0002 | 0.002 |
Erythromycin | 1–10–100–1000 | 257 ± 28 | 236 |
Fluoxetine | 0.1–0.3–1–3 | 0.39 ± 0.05 | 2.0 |
Glibenclamide | 0.2–0.6–2–6 | >6 | >6 |
Haloperidol | 0.001–0.01–0.1–1 | 0.023 ± 0.005 | 0.027 |
Ibuprofen | 0.3–3–30–300 | >300 | >300 |
Moxifloxacin | 0.3–3–30–300 | 34 ± 2 | 29 (Alexandrou et al., 2006) |
Olanzapine | 0.3–1–3–10 | 1.3 ± 0.2 | 2.1 |
Quinidine | 0.1–0.3–1–3 | 0.35 ± 0.06 | 0.6 |
d,l-Sotalol | 0.3–3–30–300 | 103 ± 20 | 154 |
Tamoxifen | 0.1–0.3–1–3 | 0.44 ± 0.06 | 0.1 (Yuill et al., 2004) |
Terfenadine | 0.003–0.01–0.03–0.3 | 0.05 ± 0.01 | 0.015 |
Thioridazine | 0.03–0.1–0.3–1–3 | 0.09 ± 0.003 | 0.096 (Kirsch et al., 2004) |
Verapamil | 0.01–0.003–0.1–0.3 | 0.2 ± 0.03 | 0.136 (Kirsch et al., 2004) |